AdvisorShares Pure Cannabis ETF (YOLO)

Key Updates

YOLO has pulled back sharply, declining 4.46% since the September 24 report, falling from $3.36 to $3.21. This reverses a portion of the four-period rally documented in prior reports, which had carried the ETF from $2.97 to $3.36 between September 16 and September 24. Despite the single-day setback, the fund retains a positive 5-day return of 6.29%, indicating the pullback follows an extended run-up and may reflect partial profit-taking rather than a trend reversal. The ETF remains down 2.73% YTD, underscoring that the recent rally has not yet been sufficient to restore year-to-date gains.

Current Trend

YTD performance stands at -2.73%, while medium-term momentum remains constructive: +15.05% over 6 months and +3.18% over 1 month. The 1-day decline of -4.46% interrupts a sequence of consecutive gains reported over the prior three periods (+2.19%, +4.45%, +5.99%), suggesting the rally that pushed the price from the $2.97 support zone to a recent high near $3.36 has encountered resistance. The current price of $3.21 sits between the prior support ($2.97-$3.04, established September 16-21) and the recent resistance near $3.36 (September 24 high). A decisive break below $3.04 would negate the recovery structure built over the past two weeks, while reclaiming $3.36 would confirm continuation of the uptrend.

Investment Thesis

YOLO's investment case is tied to sector-wide cannabis catalysts, notably ongoing consolidation activity. The Curaleaf-Aurora tender offer remains the dominant fundamental driver in the news flow, with Curaleaf pressing its case that a combined entity would generate ~$1.5 billion in LTM revenue and ~$350 million in adjusted EBITDA, plus at least $40 million in annual cost synergies. Cannabis multi-state operators and Canadian LPs held within YOLO's portfolio are directly exposed to the outcome of this M&A process, which could serve as a re-rating catalyst for the broader sector if completed, or a source of uncertainty if contested or delayed.

Thesis Status

The thesis remains intact but has not yet been validated by price action on a YTD basis. The four-session rally into September 24 suggested market participants were pricing in constructive M&A developments and sector consolidation optimism; however, the subsequent -4.46% reversal signals that gains achieved were vulnerable to profit-taking, and no new fundamental information has emerged since the September 24 report to justify a change in either direction. The Curaleaf-Aurora situation is unchanged from the prior update (no new news items), meaning the pullback appears technical/sentiment-driven rather than fundamentally triggered. The thesis remains conditional on the M&A outcome and sector-wide EBITDA trends flagged in the Curaleaf letter (Aurora's -78% adjusted EBITDA decline in H1 2026).

Key Drivers

No new news events occurred since the last report; the single available article remains the September 15 Curaleaf letter to Aurora shareholders. Key elements from this driver continue to define sector sentiment:

• Curaleaf's tender offer values Aurora at a 45% premium (US$4.00/share: 0.3463 Curaleaf shares + US$0.75 cash)
• Combined entity guidance: ~US$1.5 billion LTM revenue, ~US$350 million adjusted EBITDA, 17-country footprint
• At least US$40 million in projected annual cost synergies
• Aurora's H1 2026 net revenue and adjusted EBITDA declined 14% and 78%, respectively, versus Curaleaf shares appreciating 50% in the same period

The absence of fresh news since September 24 suggests the current price decline is driven by technical profile-taking following the prior rally rather than a fundamental deterioration.

Technical Analysis

YOLO trades at $3.21, down 4.46% on the day, after peaking near $3.36 in the previous reporting period. The 5-day return remains strongly positive (+6.29%), confirming the broader up-move is still intact despite the daily reversal. Key support is established in the $2.97-$3.04 range (September 16-21 lows); key resistance is the $3.36 level reached September 24. The current pullback places price roughly mid-range between these two technical boundaries, and a close below $3.04 would be the first bearish signal invalidating the multi-session recovery structure.

Bull Case

• Curaleaf-Aurora merger could create a sector leader with ~US$1.5 billion LTM revenue and ~US$350 million adjusted EBITDA, potentially re-rating cannabis MSO valuations broadly (PR Newswire)
• Projected cost synergies of at least US$40 million from the Curaleaf-Aurora combination signal potential margin improvement across consolidated cannabis operators (PR Newswire)
• Curaleaf's share price appreciation of 50% over H1 2026 demonstrates that strong operators within the sector are being rewarded by the market, supporting sector-wide sentiment (PR Newswire)
• 6-month return of +15.05% indicates a sustained medium-term uptrend that remains intact despite the latest daily pullback
• 5-day return of +6.29% shows the recent rally momentum has not been fully erased by the single-day decline

Bear Case

• Aurora Cannabis, a peer within the sector, reported a 14% decline in net revenue and a 78% decline in adjusted EBITDA in H1 2026, highlighting deteriorating fundamentals among Canadian LPs held in cannabis-focused portfolios (PR Newswire)
• YOLO remains down 2.73% YTD despite the recent rally, indicating the fund has not recovered its earlier-year losses
• The sharp -4.46% single-day decline erased a meaningful portion of the prior four-session gains, suggesting the rally lacked durable buying support
• Uncertainty surrounding the Curaleaf-Aurora tender offer outcome (contingent on shareholder acceptance) introduces binary risk for holdings exposed to Aurora, given the ongoing shareholder Q&A and campaign process (PR Newswire)
• Absence of new fundamental catalysts since the September 24 peak leaves the recent pullback without a clear supportive narrative, raising the risk of further downside if the $3.04 support level fails